HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement Ad Substantiation Remains Problematic – ABC Exec

This article was originally published in The Tan Sheet

Executive Summary

TV networks face the challenge of balancing consumers' safety and shareholder interests when reviewing dietary supplement ad claims, ABC Broadcast Standards VP Harvey Dzodin commented at an advertising meeting in New York

You may also be interested in...



Ad Claims Heightened Media Screening Essential – FTC’s Anthony

FTC efforts to encourage responsible review of advertising claims among media outlets have elicited, at best, a "lukewarm" response, Commissioner Sheila Anthony told the Food & Drug Law Institute annual educational conference April 16

TV Ad Disclosure Poorly Understood By Consumers - FTC Workshop

Disclosure of pertinent information in broadcast advertising is only theoretical, not actual, due to the high reading comprehension rates needed to read disclosure statements, according to attendees at a Federal Trade Commission-National Advertising Division of the Council of Better Business Bureaus workshop in Washington, D.C. May 22.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

RS130507

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel